Positive outlook for biotech M&A and funding, says report
admin 10th August 2017 Uncategorised 0M&A, investment and digital health strong for the first half of 2017
More: Positive outlook for biotech M&A and funding, says report
Source: News
M&A, investment and digital health strong for the first half of 2017
More: Positive outlook for biotech M&A and funding, says report
Source: News
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney cancer, but window still open for Bristol Myers: analyst
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney
FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst
FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufa
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ sup
M | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 |
8 | 9 | 10 | 11 | 12 | 13 | 14 |
15 | 16 | 17 | 18 | 19 | 20 | 21 |
22 | 23 | 24 | 25 | 26 | 27 | 28 |
29 | 30 | 31 |
© 1994 - 2021 B.M. Pharmaceuticals